Phase II clinical trial of Niclosamide drug for treatment of COVID-19 patients begins

The trial is a multi-centric, randomised, open label clinical study to evaluate the efficacy, safety and tolerability of Niclosamide for treating hospitalised COVID-19 patients.

published on : 6th June 2021

Reliance submits proposal for using Niclosamide as COVID drug

Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years.

published on : 3rd June 2021